logo

For the Inventor, By the Inventor

New York, NY, United States of America

Michaele B Manigrasso

This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignees: New York University, The State University of New York, Other. Active years: 2016-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michaele B Manigrasso. Retrieved from https://idiyas.com/inventor/michaele-b-manigrasso

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:

goldMedal4 out of 1,727 
 
New York University
 patents
silverMedal4 out of 2,044 
 
The State University of New York
 patents
bronzeMedal1 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 2016-2021

Loading Chart...
5 patents (USPTO):Explore Patents
1. 11192859 - Quinoline compounds as modulators of RAGE activity and uses thereof (2021-12-07),
2. 10729695 - Amino, amido and heterocyclic compounds as modulators of RAGE activity and uses thereof (2020-08-04),
3. 10265320 - Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof (2019-04-23),
4. 9364472 - Amino, Amido and heterocyclic compounds as modulators of RAGE activity and uses thereof (2016-06-14),
5. 9353078 - Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof (2016-05-31),

Title: Michaele B Manigrasso: Innovator in Pharmaceutical Compounds

Introduction

Michaele B Manigrasso is a notable inventor based in New York, NY, with a focus on pharmaceutical innovations. He holds a total of five patents that contribute significantly to the field of medicine. His work primarily revolves around compounds that modulate RAGE activity, which is crucial in various health conditions.

Latest Patents

Among his latest patents, Michaele has developed quinoline compounds that serve as modulators of RAGE activity. These compounds are designed to be used in pharmaceutical compositions for the prevention and treatment of several conditions in mammals, including diabetes complications, inflammation, neurodegeneration, obesity, cancer, ischemia/reperfusion injury, and cardiovascular diseases. Another significant patent involves amino, amido, and heterocyclic compounds, which also act as modulators of RAGE activity and have similar applications in treating various health issues.

Career Highlights

Michaele has had a distinguished career, working with prominent institutions such as the State University of New York and New York University. His contributions to research and development in the pharmaceutical field have been recognized and valued.

Collaborations

Michaele has collaborated with esteemed colleagues, including Ann Marie Schmidt and Ravichandran Ramasamy, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Michaele B Manigrasso's innovative work in pharmaceutical compounds showcases his commitment to advancing medical science. His patents reflect a deep understanding of complex health issues and a dedication to finding effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…